Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00363545
Status:
COMPLETED
Last Update Posted:
2018-06-08
First Post:
2006-08-11
Brief Title:
To Assess Immunogenicity Reactogenicity Safety of 2 Formulations of GSKs HRV Vaccine as 2-dose Vaccination Infants
Sponsor:
Organization:
GlaxoSmithKline